Development of NF1 Gene Therapy

NF1基因治疗的发展

• 批准号: 468132
• 负责人: Brosseau Jean-Philippe
• 金额: $ 4.37万
• 依托单位: Universit de Sherbrooke
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2022
• 资助国家: 加拿大
• 起止时间: 2022-02-01 至 2024-02-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=468132&lang=en
• 关键词: Brain And Nervous System; Childhood And Young Adult; Oncogenes And Tumour Suppressors

Neurofibromatosis type I is an incurable genetic disease. Patients develop disfiguring tumors that are often difficult to remove by surgery and may be fatal. This disease is caused by a genetic mutation in the gene producing neurofibromin, rendering it no

神经纤维瘤病I型是一种无法治愈的遗传性疾病。患者发展出毁容肿瘤，通常难以通过手术切除，并且可能是致命的。这种疾病是由产生神经纤维蛋白的基因突变引起的，